Sartorius (OTCMKTS:SARTF) Short Interest Update

Sartorius (OTCMKTS:SARTF) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 915 shares, a decline of 62.7% from the June 30th total of 2,451 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Sartorius Stock Performance

Shares of OTCMKTS:SARTF opened at $212.80 on Tuesday. Sartorius has a 12-month low of $181.58 and a 12-month high of $227.00. The company’s 50 day moving average price is $211.28 and its two-hundred day moving average price is $219.77. The firm has a market cap of $7.28 billion, a PE ratio of 98.98 and a beta of 0.98. The company has a quick ratio of 0.49, a current ratio of 0.95 and a debt-to-equity ratio of 0.89.

Sartorius Company Profile

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.